Taipei, Taiwan

Shing-Mou Lee

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shing-Mou Lee: Innovator in Surgical Grafts

Introduction

Shing-Mou Lee is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical technology, particularly in the area of surgical grafts. His innovative work focuses on repairing chondral defects, which are critical for joint health and mobility.

Latest Patents

Shing-Mou Lee holds a patent for "Surgical grafts for repairing chondral defects." This patent describes an implant that contains a collagen matrix embedded with chondrocyte-like cells. The invention outlines its use in repairing chondral defects and provides a method for preparing the implant. This advancement has the potential to improve surgical outcomes for patients suffering from joint issues.

Career Highlights

Throughout his career, Shing-Mou Lee has demonstrated a commitment to advancing medical technology. His work has been recognized for its innovative approach to addressing complex medical challenges. With a focus on practical applications, he continues to contribute to the field of regenerative medicine.

Collaborations

Shing-Mou Lee has collaborated with esteemed colleagues, including Feng-Huei Lin and Hwa-Chang Liu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Shing-Mou Lee is a pioneering inventor whose work in surgical grafts has the potential to transform the treatment of chondral defects. His contributions to medical technology highlight the importance of innovation in improving patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…